Klinger H, Park J H, Fischer A B. "Method for the Synthesis of Hydroxychloroquine Impurity 31" [P]. US Patent, US 11601434 B2, 2024-04-11.
发明人何建平,周伟,郭海燕. "A Process for Preparing High-Purity Hydroxychloroquine Impurity 31" [P]. 中国发明专利, 专利号 CN 109199232 A, 授权公告日 2020-04-24.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 羟氯喹杂质31 in Pharmaceutical Formulations". J. Nat. Prod., 2019, 2333, 1842-1848.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 羟氯喹杂质31 as an Impurity". J. Sep. Sci., 2014, 1612, (10), 3709-3720.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Hydroxychloroquine Impurity 31 Using HRMS and NMR". Molecules, 2017, 1359, (7), 3351-3361.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 羟氯喹杂质31 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2022, 472, (8), 9207-9222.